Latest filing published 28 Aug 2026 for 新日本製薬株式会社, €8.8M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lapris Co.,Ltd.: trading record in brief
Lapris Co.,Ltd. discloses dealings in 新日本製薬株式会社 to EDINET (Japan FSA). We count 2 filings, every one of them for a trade on 1 May 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 28 August 2026: a transaction, in 新日本製薬株式会社. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lapris Co.,Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareXTKSEDINET:S100YZ1N
- 100.0% of flowShareXTKSEDINET:S100YW4P
2 of 2 declarations